Hemostasis Management

This channel includes news and new technology innovations for devices to help stop bleeding at vascular access sites. These include coated or treated bandages to accelorate or augment the clotting cascade, vascular closure devices and compression devices, including radial artery compression systems.

 At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle, and a still micropunture sheath.

At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle and a still micropunture sheath. Photo and slides courtesy of Yader Sandoval, M.D.

Feature | Vascular Access | June 10, 2020 | Dave Fornell, Editor
Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access...
BD (Becton, Dickinson and Company, and Bard) launched the Halo One Thin-Walled Guiding Sheath, designed to perform as both a guiding sheath and an introducer sheath, for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices.
News | Vascular Access | June 08, 2020
June 8, 2020 – BD (Becton, Dickinson and Company) launched the Halo One Thin-Walled Guiding Sheath, designed to perform...
News | Radial Access | December 30, 2019
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in...
Videos | Vascular Closure Devices | October 17, 2019
Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend...
Merit Medical Launches PreludeSync Evo Radial Compression Device
News | Hemostasis Management | August 29, 2019
August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial...
Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.
Technology | Vascular Closure Devices | April 03, 2019
April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore...
PreludeSync Distal Compression Device Available Globally
Technology | Hemostasis Management | February 01, 2019
February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available...
FDA Approves Vascade MVP Vascular Closure System
Technology | Vascular Closure Devices | December 20, 2018
December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food...
PerQseal Large Bore Closure Device Launches in Europe
News | Vascular Closure Devices | November 21, 2018
November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for...
Technology | Vascular Closure Devices | November 05, 2018
November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure...
Videos | Hemostasis Management | September 27, 2018
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at...
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

 

Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...
Vascade Vascular Closure System Approved for Femoral Vein Closure
Technology | Vascular Closure Devices | April 10, 2018
April 10, 2018 – Cardiva Medical announced the company received U.S. Food and Drug Administration (FDA) approval for an...
The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomies...
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices | October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc. announced today an agreement to sell certain products from their...